Hakutulokset - Cecilia M. Fenoglio‐Preiser

  • Näytetään 1 - 10 yhteensä 10 tuloksesta
Tarkenna hakua
  1. 1
    The future of prognostic factors in outcome prediction for patients with cancer

    The future of prognostic factors in outcome prediction for patients with cancer Tekijä L P Fielding, Cecilia M. Fenoglio‐Preiser, Laurence S. Freedman

    Julkaistu 1992
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential

    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential Tekijä S. Coverlizza, Mauro Risio, Andrea Ferrari, Cecilia M. Fenoglio‐Preiser, F. P. Rossini

    Julkaistu 1989
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    American Joint Committee on Cancer prognostic factors consensus conference

    American Joint Committee on Cancer prognostic factors consensus conference Tekijä Carolyn C. Compton, Cecilia M. Fenoglio‐Preiser, Norman M. Pettigrew, L P Fielding

    Julkaistu 2000
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Serrated Polyps of the Large Intestine

    Serrated Polyps of the Large Intestine Tekijä Dale C. Snover, Jeremy R. Jass, Cecilia M. Fenoglio‐Preiser, Kenneth P. Batts

    Julkaistu 2005
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps

    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps Tekijä Won Chul Lee, Alfred I. Neugut, Gail Garbowski, Kenneth A. Forde, Michael R. Treat, J. Ways, Cecilia M. Fenoglio‐Preiser

    Julkaistu 1993
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer Tekijä Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression

    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression Tekijä Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 Tekijä Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation Tekijä Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... Tekijä Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: